Cabozantinib in Combination With Enfortumab Vedotin for Locally Advanced or Metastatic Urothelial Cancer

Clinical trial NCT04878029 · RECRUITING

Trial details

NCT number: NCT04878029
Sponsor: Emory University
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Infiltrating Bladder Urothelial Carcinoma With Squamous Differentiation Locally Advanced Urothelial Carcinoma Metastatic Urothelial Carcinoma Unresectable Urothelial Carcinoma

Start date: 2021-07-23
Primary completion: 2027-11-13
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.